Macrogenics (MGNX) Change in Acquisitions & Divestments (2016 - 2026)
Macrogenics' (MGNX) quarterly Change in Acquisitions & Divestments came in at $47.6 million in Q1 2026, up 159.69% year-on-year from $18.3 million in Q1 2025, and up 106.34% on a QoQ basis from $23.1 million in Q4 2025.
Macrogenics (MGNX) Change in Acquisitions & Divestments (2016 - 2026) Analysis & Trends
Macrogenics (MGNX) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $47.6 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 159.69% year-over-year to $47.6 million in Q1 2026; TTM through Mar 2026 was $125.4 million, a 4.7% decrease from a year earlier, with the FY2025 full-year figure at $96.1 million, down 49.41% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $47.6 million, up from $23.1 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for MGNX reached as high as $76.8 million in Q1 2024 and fell as low as $8.6 million in Q2 2025.
- Historically, Change in Acquisitions & Divestments has averaged $40.6 million across 5 years, with a median of $41.0 million in 2024.
- Across the five-year window, Change in Acquisitions & Divestments surged 222.29% in 2024 and tumbled 84.77% in 2025, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $39.8 million in 2022, then soared by 55.75% to $61.9 million in 2023, then tumbled by 74.36% to $15.9 million in 2024, then jumped by 45.44% to $23.1 million in 2025, then jumped by 106.34% to $47.6 million in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $47.6 million in Q1 2026, $23.1 million in Q4 2025, and $46.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Macrogenics | 249.36 Mn | 182.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.64 Mn |
| Mar 31, 2026 | 47.64 Mn |
| Dec 31, 2025 | 23.09 Mn |
| Dec 31, 2025 | 23.09 Mn |
| Sep 30, 2025 | 46.12 Mn |
| Sep 30, 2025 | 46.12 Mn |
| Jun 30, 2025 | 8.59 Mn |
| Jun 30, 2025 | 8.59 Mn |
| Mar 31, 2025 | 18.35 Mn |
| Mar 31, 2025 | 18.35 Mn |
| Dec 31, 2024 | 15.88 Mn |
| Dec 31, 2024 | 15.88 Mn |
| Sep 30, 2024 | 41.00 Mn |
| Sep 30, 2024 | 41.00 Mn |
| Jun 30, 2024 | 56.40 Mn |
| Jun 30, 2024 | 56.40 Mn |
| Mar 31, 2024 | 76.75 Mn |
| Mar 31, 2024 | 76.75 Mn |
| Dec 31, 2023 | 61.91 Mn |
| Dec 31, 2023 | 61.91 Mn |